SolasCure

SolasCure is a biotechnology firm developing Aurase Wound Gel, an investigational biologic designed for the treatment of chronic wounds. The product utilizes continuous enzymatic debridement to prepare the wound bed while simultaneously activating endogenous repair pathways to accelerate healing. The company targets the global healthcare market, specifically focusing on patients with non-healing wounds that have not responded to standard maintenance therapies.